Public Policy

Trump's Tax Bill May Reverse Obamacare Coverage Gains
Public Policy Trump's Tax Bill May Reverse Obamacare Coverage Gains

Introducing Faisal Zain, a trailblazer in healthcare technology and medical device innovation. His expertise brings a fresh perspective to the intricate world of health policy and reform, particularly as we navigate the changes proposed by President Trump’s tax and spending bill concerning the A

Trend Analysis: Medicaid Policy Shifts
Public Policy Trend Analysis: Medicaid Policy Shifts

Medicaid, one of the most substantial healthcare programs in the United States, serves as a vital lifeline for over 70 million low-income and disabled individuals, including nearly half of the nation's children. Despite its importance, recent political maneuvers threaten to reshape the

GOP's New Strategy: Shrinking Medicaid Via Reconciliation
Public Policy GOP's New Strategy: Shrinking Medicaid Via Reconciliation

Behind the Curtain of Political Strategy In a bold political maneuver, the GOP has leveraged budget reconciliation—often a vehicle to increase health coverage—to potentially reduce Medicaid benefits. As debates intensify, healthcare stakeholders and political analysts are keenly aware of shifts tha

Unraveling PANS and PANDAS: A Call for Awareness and Solutions
Public Policy Unraveling PANS and PANDAS: A Call for Awareness and Solutions

A sudden transformation in a child's behavior can be bewildering. Imagine a lively, playful child becoming distant and prone to sudden outbursts seemingly overnight. These abrupt changes are leaving loved ones puzzled and desperate for answers. The Hidden Crisis Lurking Beneath the Surface An

Proposed Medicaid Cuts Threaten Rural Healthcare Access
Public Policy Proposed Medicaid Cuts Threaten Rural Healthcare Access

The Trump administration's One Big Beautiful Bill Act has proposed significant Medicaid funding reductions, representing the largest in history and presenting alarming challenges for rural healthcare systems. With estimates suggesting that over 10 million Americans could lose coverage, the

Can Reyobiq Revolutionize Pediatric Brain Tumor Treatment?
Public Policy Can Reyobiq Revolutionize Pediatric Brain Tumor Treatment?

In a groundbreaking development for pediatric oncology, the U.S. Food and Drug Administration (FDA) has approved a clinical trial for Reyobiq (Rhenium Re186 Obisbemeda), a promising radiation therapy aimed at treating aggressive brain tumors in children. This trial has generated significant

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later